This downturn is primarily attributed to a continued increase in medical costs for government-backed insurance plans, ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...

U.S. stock futures pointed to a steady open on Friday following record closes for the S&P 500 and the Nasdaq in the previous ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Centene ( NYSE: CNC) has been downgraded to Neutral from Overweight at Cantor citing heightened uncertainty in the company's ...

The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE ...

Centene Corporation (NYSE:CNC) experienced a challenging Tuesday evening, witnessing a 25% drop in shares during after-hours trading on July 1st. The significant decline in the healthcare giant's ...